ZWINT, NUSAP1 and RAD51AP1 expression showed an increasing trend in the progression of NAFLD (Figure 4C), but KIF22, KIAA0101 and UHRF1 exhibits a different expression profile in different stages of the NAFLD (Supplementary Figure S1). This evidence concerns the gene PCLAF and metabolic dysfunction-associated steatotic liver disease.